NeoMend (Acquired)

Resorbable pegylated hydrogel for surgical wound sealing/adhesion prevention/sustained and targeted drug delivery.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NeoMend (Acquired) plus 5589 other startups.

Start Free 7 Day Trial Now

Learn More About NeoMend (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups


Companies We Work With